based on its R100 adeno-associated virus (AAV) transgene cassette. Unlike other virus-based vectors used for retinal diseases, R100 treats the entire retinal surface at low doses and does not ...

According to Dr Erik Wiklund, CEO of Circio, Norway: “Gene therapies have been available for more than 30 years, and there are now AAV-based and ... a genetic cassette that forms a circular ...